ReviewCancer journal (Sudbury, Mass.)
Targeting CD30 Using Brentuximab Vedotin in the Treatment of Hodgkin Lymphoma.
Anna Alperovich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
22 papers cite it
trialcites it
ReviewCancer journal (Sudbury, Mass.)
Anna Alperovich et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.